Connect with us

Health

First aerosolized inhaled COVID-19 vaccine proven safe in Phase-I clinical trials: developers – Global Times

The world’s first aerosolized inhaled adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV), jointed developed by CanSino…

Published

on

Article feature image
ADVERTISEMENT

CanSino’s one-shot COVID-19 vaccine
The world’s first aerosolized inhaled adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV), jointed developed by CanSino Biologics (CanSinoBIO) and researchers from the Institute of Military Medicine under the Academy…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending